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ABSTRACT 
Objective: The present study was aimed to formulate fast dissolving tablets (FDTs) of Aprepitant (APT) using natural and synthetic 
superdisintegrants with the desired onset of action, increased bioavailability by reducing the frequency of dosage and also reduce the first-pass 
metabolism of the drug. 
Methods: In this research, the gum isolated from cordia dichotoma was investigated as super disintegrants in fast dissolving tablets (FDTs). The 
aprepitant tablets were prepared separately using cordia dichotoma (natural), sodium starch glycolate and croscarmellose sodium (synthetic) as 
superdisintegrants by direct compression method. The tablets were evaluated for various precompression and post-compression parameters.  
Results: The optimized formulation (APT F3) of cordia dichotoma (8%) showed satisfactory physicochemical properties, minimum disintegration 
time (34 seconds) and highest dissolution rate (86.52%) in 10 min than the other synthetic superdisintegrants. Also, the pharmacokinetic study of 
the optimized formulation showed effective results as compared with marketed product of aprepitant. 
Conclusion: The developed formulation can improve the onset of action as well as improve patient compliance. 
Keywords: Aprepitant, Superdisintegrants, Fast dissolving tablet, Direct compression, Evaluation, In vivo studies 
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INTRODUCTION 
Nausea is an unpleasant sensory and emotional experience 
accompanied by an autonomic driven physiological change of paller 
and upper GI track hyper secretion [1]. Current oral formulation of 
aprepitant are indicated for administration of multiple doses, which 
was due to the half-life of approximately 9-13 h with a time to peak 
plasmas level of 4 h [2]. 
Approximately 40% of patients who receive chemotherapy have 
experienced with nausea and vomiting [3, 4]. Control of nausea and 
vomiting following chemotherapy and surgery has been improved in 
recent years due to the advancement of novel, effective, and better-
tolerated antiemetic therapies [5-7]. Conventional oral drug delivery 
systems, including solutions, suspension, tablets and capsules are 
difficult to administer to patients with dysphagia. Swallowing 
problems can also be appear often in specific populations, including 
pediatric, elderly, nauseated patients and developmentally disabled 
patients. In addition to these difficulties convenience is also a 
notable concern associated with oral antiemetics like the patients 
taking tablet formulations require water to ease swallowing, which 
is not always available [8, 9]. Also, crushing tablets or removing 
contents from capsules may change the absorption of a drug. In 
addition to change in nontraditional drug delivery systems, oral 
delivery formulations have continued to develop to enhance the 
dissolution and absorption. Fast dissolving tablets (FDTs) have been 
designed to allow a solid dose to be rapidly dissolved in the oral 
cavity without the need for water [10-12]. 
Several approaches have been used to formulate FDTs like freeze-
drying, tablet molding, sublimation, direct compression, spray 
drying etc. Out of theses direct compression and lyophilization have 
become the most popular used techniques. The tablets prepared by 
lyophilization technique have very porous structures and hence 
allow fast disintegration of the tablets. However, high porosity leads 
to poor physical resistance, in addition to its cost-intensive 
production process. On the other hand the tablets produced by 
direct compression method can be hard and attain low friability. 
This method requires efficient disintegrants to enhance the breaking 
up of the tablets [12-14]. 
Hence, based on the rationale of the proposed research work, the 
aim of the present study was to develop and formulate fast 
dissolving tablet of aprepitant by direct compression method for 
the direct absorption of drug via transmucosal lining to the 
systemic circulation. The proposed formulation has the potential 
to improve disintegration time and possess sufficient mechanical 
strength to produce rapid onset of action and patient 
compliance. 
MATERIALS AND METHODS 
Materials 
Aprepitant was obtained from Hetero Labs Ltd, Baddi, India. Cordia 
dichotoma fruit was collected from northen region of Rajasthan, 
microcrystalline cellulose (SD Fine Chemicals), sodium starch glycolate, 
croscarmellose sodium (DFE Pharma) and all other chemicals were used 
of analytical grade without any further modification. 
Methods 
Isolation of gum from cordia dichotoma fruit 
The whole plant of Cordia dichotoma (family Boragenaceae) was 
procured from northen region on Rajasthan’s district Sri 
Ganganagar. It was shade dried and stored in a tight closed 
container. This variety was identified and authenticated by as Cordia 
dichotoma from National institute of science communication and 
information Resources (NISCAIR/ RHMD/Consult/1450/48). 
It was taken as plant parts such as fruit have been reported for 
possessing super disintegrant activity. Plant material was washed, 
then macerated with water (1:2) and stirred for 3 h. The viscous 
solution was obtained by addition of 95% ethanol with continuous 
stirring and was filtered through the muslin cloth. Precipitation of 
the mucilage was carried out. The precipitated polysaccharide was 
dried in oven at 40-45 °C. The dried product was powdered and 
passed through sieve no 60. The product was kept in airtight 
containers. The isolated gum was investigated for physic-chemical 
properties such as swelling index, solubility, pH and loss of drying 
and its powder flow properties [15-18]. 
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Physicochemical characterization of the polysaccharide 
obtained from cordia dichotoma fruit 
Swelling index (SI) 
SI is defined as the determination of the amount of the liquid taken 
by the powder. The sample (1g) was filled into the 50 ml measuring 
cylinder. After placing the solid sample, it was tapped 10 times to 
obtain possibly the same packaging of bed. Phosphate buffer pH 6.8 
(25 ml) was added by shaking every 10 min for 1 h [19]. The swollen 
mass was allowed to stand for 24 h. The SI was estimated as:  
SI = 100 ∗ (Ht − Hi)/Hi 
Where Hi = initial height of material before hydration; Ht = Height of 
hydrated material. 
Determination of pH 
pH was investigated by taking 1% w/v dispersion of cordia 
dichotoma using digital pH meter. The pH was noted after immersing 
the electrode of the pH meter in contact with the dispersion [20]. 
Loss of drying (LOD) 
The presence of moisture in the powder may affect the stability of 
the dosage form. Therefore loss of drying was determined by loss of 
drying technique. The sample was weighed and dried in oven for 2 h. 
The sample was allowed to cool in desiccator and weighed again. 
The percentage weight loss was determined by using the formula. 
% LOD = 100 ∗
W1 − W2
W1  
Where W1= initial weight of powder; W2= final weight of powder 
Drug excipient interaction study 
Fourier transform infrared spectroscopy (FTIR) 
The physical mixtures of aprepitant and cordia dichotoma were used 
to check the physicochemical compatibility by FTIR absorption 
spectra. The graph was recorded in the range of 4000–400 cm-1
Differential scanning calorimetry (DSC) 
 by 
KBr pellet method using FTIR spectrophotometer (Spectrum GX, 
Perkin-Elmer, USA). 
The thermal properties of the pure drug and polysaccharide with 
their mixtures were assessed using differential scanning calorimeter 
using DSC-PYRIS-1 (Perkin-Elmer, USA). The analysis was achieved 
with heating at 50-48 °C and a rate of 10 °C min-1
Preparation of fast dissolving tablets of aprepitant 
 in an inert nitrogen 
atmosphere. 
Direct compression method was used to prepare fast dissolving 
tablets using natural and synthetic superdisintegrants (table 1). The 
raw material was passed through sieve no 100 prior to mixing. 
Lubricants were added in this mixture at last. The blend was then 
converted into the tablet by using a single punch machine (table 1). 
The prepared tablets were evaluated for pre and post parameters. 
The evaluated tablets were compared with the tablets prepared by 
synthetic superdisintegrants. 
Precompression parameters of the powder blend 
The physical mixture of the blend was evaluated for its micrometric 
properties (bulk density and tapped density) and flow properties 
(angle of repose, compressibility index and Hausner's ratio) [21]. 
 
Table 1 Composition of fast dissolving tablets 
Ingredients (mg) APT F1 APT F2 APT F3 APT F4 APT F5 APT F6 APT F7 APT F8 APT F9 
Aprepitant 40 40 40 40 40 40 40 40 40 
Cordia dichotoma 4 6 8 - - - - - - 
Sodium starch glycolate - - - 4 6 8 - - - 
Croscarmellose sodium - - - - - - 4 6 8 
Avicel PH102 87 85 83 87 85 83 87 85 83 
Mannitol 60 60 60 60 60 60 60 60 60 
Sodium Saccharine 1 1 1 1 1 1 1 1 1 
Magnesium stearate 4 4 4 4 4 4 4 4 4 
Talc 4 4 4 4 4 4 4 4 4 
 
Angle of repose 
The angle of repose was determined using funnel method. The funnel 
was mounted at fixed height on the stand. A fixed weight quantity of 
blend was allowed to pour through the funnel. The height and diameter 





Hausner ratio and compressibility index 
The Hausner ratio and compressibility index involves the measuring of 
bulk volume (Ho) and tapped volume (Hf). The calculations are done as:  
Compressibility index = 100 ∗ (Ho − Hf)/Ho 
Hausner ratio = (Ho/Hf) 
Evaluation of post compression parameters of FDTS 
Weight variation 
Weight variation test was performed on twenty tablets as per USP, 
calculating the individual weight and average weight and then 
comparing the individual tablet weights to the average. The average 
weight of one tablet was noted [22]. 
Tablet crushing strength 
Tablet crushing strength of each formulation was noted using 
Monsanto Hardness Tester. It was determined to check the 
condition of tablets during storage, shipping and handling before 
usage. 
Friability (% F) 
Roche friabilator was used to determine the friability of the tablets. 
Preweighed tablets were placed in the friabilator at a height of 6 
inch and subjected to revolve at 25 rpm for 4 min [23]. Tablets were 
reweighed after removing fines. The friability (F %) was calculated 
by the formula. 
%F = 1 −
loss in final weight
initial weight
∗ 100 
Disintegration time (DT) 
US FDA described that the disintegration of the tablet is achieved in 
the oral cavity. Phosphate buffer pH 6.8 (6 ml) was taken in a 25 ml 
beaker as amount of saliva in the oral cavity is limited (approx. 6 
ml). The temperature was maintained at 37±2 °C [24, 25]. A tablet 
was placed into the beaker and time required for complete 
disintegration of the tablet was noted.  
Wetting time (WT) 
A piece of circular tissue paper was kept in a petri dish containing 6 
ml of phosphate buffer (pH 6.8) containing amaranth dye. The tablet 
was placed on the surface of tissue paper and the time to reach the 
solution at the upper surface of the tissue paper was determined as 
wetting time of tablet.  
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Uniformity of content 
Ten tablets were crushed to the powder and powder equivalent to 
40 mg of drug was dissolved in the phosphate buffer pH 6.8. This 
solution was filtered and injected into the HPLC. The drug content 
was determined by an average of three random samplings of all 
batches [26]. 
In vitro drug release studies 
30 ml phosphate buffer (pH 6.8) with 1% w/v SLS in a beaker 
(37±0.5 °C) was used to determine the dissolution profile of tablets. 
Whole assembly was then placed on a shaker. 1.0 ml sample aliquot 
was withdrawn and replaced with the same fresh media at different 
time intervals. Samples were filtered and diluted with phosphate 
buffer (pH 6.8). The filtrate was analyzed by using HPLC. The in vitro 
release data obtained was exposed to zero-order kinetics to 
understand the release mechanism [27, 28]. 
In vivo study design study 
New Zealand healthy male rabbits (weighing 2.6-3.1 kg) were 
selected for the study. The experimental animals were procured 
from MMIMSR MM University, Mullana. All animal experiments were 
carried out after approval of the protocol by the Institutional Animal 
Ethical Care (IAEC) committee (RIP/IAEC/2016-2017/07) 
guidelines for the use and care of experimental animals. The 
procured rabbits were acclimated for 10 d in proper cages at air 
conditioned temperature having average feed intake around 40-50 g 
and free access to water. 
For in vivo study all rabbits were fasted for 12 h before 
administration of formulations and then divided into two groups. 
One group received aprepitant loaded FDT whereas the other group 
received the marketed formulations (Aprepitant equivalent to 1 
mg/kg). The FDT was carefully placed on the rabbit tongue with 
body restraint device in which the animal's head was exposed and 
lifted apart the gums. The mouth of animal was wetted with small 
amount of water [29, 30] and tablet was placed in the mouth. A 
gentle strain was also applied to restrict the mouth in order to 
confirm the complete breakdown of the tablet [31]. About 0.5 ml 
blood samples were withdrawn from the peripheral vein of each 
rabbit at the interval of 0,1,2,3,4,5,7,9,12,24 h for the determination 
of pharmacokinetic study. 
Preparation of plasma samples for HPLC analysis 
The blood sample (0.5 ml) containing disodium EDTA was 
withdrawn in the centrifugation tube. The sample was centrifuged at 
5000 for 10 min. The plasma proteins were precipitated with the 
addition of acetonitrile [32-34]. The supernatant was transferred to 
a test tube and evaporated to the dryness. The residue was 
reconstituted with acetonitrile and dilute phosphoric acid to 
determine aprepitant in blood sample by HPLC method. 
Pharmacokinetic parameters was analyzed in this study 
RESULTS 
The dried polysaccharide powder isolated from cordia dichotoma 
was brown in color. Further, the polysaccharide was evaluated for 
physicochemical characterization as shown in table 2. 
 
Table 2: Physicochemical properties of Cordia dichotoma 
S. No. Parameters Results 
1 State Solid 
2 Color Brown 
3 pH 6.9-7.3 
4 Solubility Soluble in hot water, insoluble in organic solvent like methanol, ethanol, chloroform. 
5 Swelling index 97% 
6 Loss of drying 8.34% 
 
The polysaccharide is freely soluble in hot water and forms viscous 
solution but practically insoluble in organic solvent. The pH of 1% 
w/v solution of polysaccharide was found to be near neutral. Loss on 
drying was observed within acceptable limits. The FTIR spectra 
obtained for aprepitant showed strong absorption peak at 1704 
cm−1 which specified C=O stretching, C-H stretching over the range 
1500–1600 cm−1 ,  C-F stretching at 1132 cm−1. The FTIR of cordia 
dichotoma sample presented characteristic peak at 3449 cm-1 which 
indicated C=O stretching vibration peak. The strong peak at 2924 
cm-1 specified C-H bond. The peak at 1622 cm-1 indicated presence of 
saponins glycosidic bond and the peak at 1407 cm−1
  
 showed a O-H 
bond indicating the presence of flavonoids. 
 
Fig. 1: Comparison of FT-IR of cordia dichotoma, aprepitant (APT) and mixture of both 
 
A DSC thermogram of pure polysaccharide showed endothermic peak at 
148 °C corresponding to its melting point and pure aprepitant displayed 
endothermic peak at 248.2 °C. The transition temperature for the 
physical mixture was decreased in the melting point by approx 10-15 °C. 
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Fig. 2: Comparison of DSC of cordia dichotoma, aprepitant (APT) and mixture of both 
 
 
Fig. 3: Graphical presentation of bulk density and tapped density (mean±SD, n = 3) 
 
 
Fig. 4: Graphical presentation of flow properties of all batches (mean±SD, n = 3) 
 
The results from the pre-compression parameters of powder blend 
revealed good flow properties in well acceptable limits as shown in 
fig. 3 and 4. 
Aprepitant fast dissolving tablets were prepared by direct 
compression method using natural and synthetic superdisintegrants 
in optimized concentration and evaluated according to the post-
compression parameters. 
The average weight of FDTs batches were found in the range of 
198.7-202.4 mg signifying weight variation is uniform. The mean 
hardness values for all the batches were found to be 2.6-3.8 kg/cm3
All the batches of FDTs contained 98.56 to 101.87% of drug content 
which indicated the uniformly distribution of the drug. The in vitro 
drug release results indicated that the speed of disintegration 
depends upon swelling pressure, surface area and hydration 
capacity. On increasing the concentration of cordia dichotoma 
(natural super disintegrants), faster the wetting and disintegration 
of tablets which may be due to rapid absorbing nature including 
swelling and capillary action of polysaccharide.  
indicating hardness of the tablet. The %age friability was found to be 
in the range of 0.45 to 0.72% revealing physical integrity of the 
tablet. 
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Fig. 5: Weight Variation of all batches (mean±SD, n = 3) 
 
 
Fig. 6: Graphical presentation of hardness and friability of all batches (mean±SD, n = 3) 
 
 
Fig. 7: Drug content of all batches (APT F1-APT F9) 
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Fig. 8: Graphical presentation of DT and WT of all batches (mean±SD, n = 3) 
 
On the contrary, when the concentration of SSG and CCS (synthetic 
superdisintegrants) was increased, this had a negative effect on the 
disintegration of the tablets. It may be due to the gel layer formation, 
which may hinder the penetration of medium and hence 
disintegration of the tablet [35, 36]. 
The plasma concentration-time profile was obtained for animal 
pharmacokinetic study (fig. 10). Pharmacokinetic parameters 
including AUC, AUMC, plasma concentration (Cmax), time to reach 
Cmax (Tmax
  
) and mean residence time (MRT) were determined using 
Winnonlin Software. 
 
Fig. 9: Comparative study of percentage drug release of tablet formulations 
 
 
Fig. 10: The pharmacokinetic profile of optimized fast dissolving tablet and marketed product (mean±SD, n = 3) 
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The average peak plasma-concentration time profile obtained from 
APT F3 signifying an increase in AUC as compared with marketed 
product. Similarly, there was increase in rate of absorption (Cmax) 
for APT F3 (table 3), representing that aprepitant was more 
promptly absorbed in the fast dissolving tablet and attaining higher 
plasma concentration in short intervals than marketed formulation.
  
Table 3: Pharmacokinetic parameters 
PK parameters APT F3 Marketed product 
AUC(ng. h/ml) 5774±278.42 4609±234.78 
Tmax (h) 2.00±0.45 4.00±0.47 
Cmax (ng/ml) 450±25.45 341±17.43 
AUMC (ng. h2 66136±2341.88 /ml) 51672±1987.54 
MRT (h) 11.4541±0.32 11.2111±0.37 
*All values are expressed as mean±SD, n = 3 (for standard deviation), the higher values of pharmacokinetic parameters indicated the improvement 
in bioavailability of the drug by formulating them into fast-dissolving tablets. 
 
DISCUSSION 
The polysaccharide obtained from cordia dichotoma was brown, 
freely flowing powder. The main concern was to select the suitable 
concentration of super disintegrants to develop a successful fast 
dissolving tablet. It was studied for powder flow properties, swelling 
index, pH and loss of drying [37]. The results were found within the 
acceptable limits of the above properties as shown in table 2. The 
FTIR-ATR of the aprepitant loaded super disintegrants indicated the 
characteristic peaks which indicate purity of drug and polymer; 
hence there was no interaction between drug and other excipients 
as shown in fig. 1. DSC also indicated that there was no change in 
aprepitant in the fast dissolving tablet as shown in fig. 2. Due to its 
good swelling properties, an attempt was made to prepare the fast 
dissolving tablet with polysaccharide to explore the potential as 
super disintegrants. The micrometric properties of polysaccharide 
indicated good packing and flow properties as shown in fig. 3 and 4. 
The fast dissolving tablet of aprepitant was prepared by direct 
compression method using natural and synthetic superdisintegrants 
in the same concentration. The prepared tablets were evaluated for 
its post-compression properties. The weight variation was complied 
with pharmacopoeial limit as shown in fig. 5. The friability and 
hardness study indicated the good physical and mechanical strength 
of the tablet (fig. 6). The percent drug content of tablets was within 
acceptable range indicated uniformity of content in all formulations 
as shown in fig. 7. 
The tablets prepared by polysaccharide acquired less wetting time 
and in vitro disintegration time. It could be due to higher swelling 
properties of polysaccharide which increased the water absorption 
capacity and thus tablets disintegrated quickly as compared to 
synthetic properties as shown in fig 8. A rapid increase in drug 
penetration increased the drug porosity and thus, improved the 
dissolution of the drug. In case of synthetic superdisintegrants, 
dissolution occurred slowly because of formation of viscous gel layer 
[38] Thus, it was concluded from in vitro drug release study that APT 
F3 was selected as the best formulation as shown in fig. 9. The 
different pharmacokinetic parameters (AUC, AUMC, Tmax, Cmax and 
MRT) were estimated from the data obtained. The results suggested 
enhancement in AUC and AUMC when aprepitant was administered 
in fast dissolving tablet. Moreover, there was no significant 
difference in Tmax and MRT suggesting that different forms of APT 
in dosage did not influence mean residence time and maximum time 
to attain the maximum concentration of aprepitant [39]. 
Thus APT F3 indicated higher rate dissolution as compared to 
synthetic superdisintegrants. The optimized fast dissolving tablet 
showed a 34 sec disintegration time with sufficient wetting time and 
86.52% drug release. Further, a significant difference in AUC and 
AUMC of the formulation indicated improvement in the oral 
bioavailability of aprepitant. 
CONCLUSION 
The study was aimed to formulate fast dissolving tablets of anti-
emetic drug aprepitant to achieve faster drug release to control in 
nausea and vomiting. An increased concentration of polysaccharide 
leads to significant effect on the disintegration as well as dissolution 
rate. Improvement in pharmacokinetic parameters (AUC, Cmax, 
tmax, AUMC and MRT) and in bioavailability offer advantages in 
terms of the quick onset of action and patient compliance as 
compared with marketed product. Hence, it can be concluded that 
the cordia dichotoma polysaccharide acts as good super 
disintegrants as compared to synthetic agents. 
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